MAI Capital Management - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 36 filers reported holding OCUPHIRE PHARMA INC in Q4 2022. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$1,526,518
-27.5%
455,677
-6.1%
0.02%
-25.8%
Q2 2023$2,105,108
+13.5%
485,048
-1.9%
0.03%
+6.9%
Q1 2023$1,855,088
+19.4%
494,690
+12.4%
0.03%
+11.5%
Q4 2022$1,553,451
+116.7%
440,071
+23.3%
0.03%
+100.0%
Q3 2022$717,000356,9480.01%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 368,003$1,232,8122.32%
Knoll Capital Management, LLC 100,000$335,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 828,628$2,775,9040.18%
Diametric Capital, LP 56,059$187,7970.08%
THOMPSON DAVIS & CO., INC. 17,000$56,9500.07%
MAI Capital Management 455,677$1,526,5180.02%
TRUST CO OF TOLEDO NA /OH/ 30,963$103,7260.02%
BEDEL FINANCIAL CONSULTING INC 15,000$50,2500.01%
Legato Capital Management LLC 10,098$33,8280.01%
Stokes Family Office, LLC 13,030$43,6510.01%
View complete list of OCUPHIRE PHARMA INC shareholders